Skip to content

Study · Observational study · n = 73 · 1999

3 results

[Use of semax at a follow-up of patients with posthypoxic encephalopathy].

Alekseeva GV, Bottaev NA, Goroshkova VV

Anesteziologiia i reanimatologiia1 Jan 1999

PMID10199046 (opens in a new tab)PepBankPUB-10199046
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanObservational studySafety outcome

    In patients with posthypoxic encephalopathy, EEG showed episodes of paroxysmal activity after semax injection in some cases.

    In plain wordsIn patients with posthypoxic encephalopathy, brain-wave tests showed episodes of abnormal activity after a semax injection in some cases.

    Peptide
    Semax
    Outcome
    IncreaseParoxysmal EEG activity after injection
    Study

    n = 73

    Outcome group
    Adverse events · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In some cases EEG showed episodes of paroxysmal activity after semax injection
    1 context sentence
    Summary · context
    Effect of a neuropeptide semax is studied in 73 patients with various symptoms of posthypoxic encephalopathy in remote period.
  2. 02HumanObservational studyEfficacy outcome

    In patients with posthypoxic encephalopathy, semax therapy was effective in those with mnestic (memory) disorders.

    In plain wordsIn patients with posthypoxic encephalopathy, semax therapy was effective in those with memory disorders.

    Peptide
    Semax
    Outcome
    Direction not reportedMnestic disorders in posthypoxic encephalopathy
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The therapy was effective in patients with mnestic disorders; the drug effect was potentiated by an adaptogen oxiterm and by supraorbital electrophoresis.
    1 context sentence
    Summary · context
    Effect of a neuropeptide semax is studied in 73 patients with various symptoms of posthypoxic encephalopathy in remote period.

Studies that did not test the peptide alone1

In this study, Semax was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Semax.

  1. 03HumanNot a test of Semax aloneObservational studyEfficacy outcome

    In patients with posthypoxic encephalopathy, the drug effect was potentiated by the adaptogen oxiterm and by supraorbital electrophoresis.

    In plain wordsIn patients with posthypoxic encephalopathy, adding an adaptogen (oxiterm) or electrophoresis strengthened the effect of the treatment.

    Peptide
    Semax
    Outcome
    IncreasePotentiation of semax effect by oxiterm and supraorbital electrophoresis
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition

    Source sentences

    Summary
    the drug effect was potentiated by an adaptogen oxiterm and by supraorbital electrophoresis.
    1 context sentence
    Summary · context
    Effect of a neuropeptide semax is studied in 73 patients with various symptoms of posthypoxic encephalopathy in remote period.

    In this study, Semax was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semax.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.